M&A in pharma
Explores the merits of mega-deal in contrast to a more measured portfolio growth strategy
Successful Licensing
Negotiating & Drafting Optimum Pharmaceutical Deals
| Publication Date | February 1999 |
| ISBN | 1860673937 |
| Pages | 0 |
| Tables | n/a |
| Figures | n/a |
Print £300 $565 |
Add to Basket |
This report provides a comprehensive guide to the business development processes involved in assessing product opportunities, negotiating deals and implementing crucial partnerships.
It shows you how to evaluate the uniqueness of an opportunity, together with key aspects involved in the negotiation, the development scope of a partnership and the financial returns involved in any venture.
Key Benefits:
- Highlights the essential winning factors in determining successful pharmaceutical strategies and product opportunities
- Evaluates licensing strategies at every stage from concept through to delivery
- Provides a full explanation of corporate strategies, business development strategies, due diligence, valuation techniques, negotiation issues and key terms in the agreement
- Provides guidance on defining business development strategies and business potential
- Identifies potential licensing partners
- Evaluates the different types of agreements available
- Assesses financial considerations
- Offers advice on overcoming common pitfalls
Content
Executive summary
Chapter 1: Corporate Strategies Collaborations Mergers/Acquisitions Business Development Strategies
Chapter 2: Evaluation and Due Diligence- Scientific, Regulatory and Commercial Issues
Chapter 3: Evaluation and Due Diligence- Intellectual Property Planning an IPR Due Diligence Exercise Patents - Planning a Strategy
Chapter 4: Gaining Access to Technology and Information- Confidentiality Issues
Chapter 5: Issues of Negotiation
Chapter 6: Overview of Letters of Intent Research Agreements
Chapter 7: Financial Evaluation of Opportunities
Chapter 8: Developing and Drafting the Agreement Performance by the Licensee
Chapter 9: Focus on: Confidentiality and Intellectual Property Rights Patents
Chapter 10: Focus on: European Competition and Free Movement Law Parallel Imports
Chapter 11: Focus on: Regulatory Affairs
Executive summary
Chapter 1: Corporate Strategies Collaborations Mergers/Acquisitions Business Development Strategies
Chapter 2: Evaluation and Due Diligence- Scientific, Regulatory and Commercial Issues
Chapter 3: Evaluation and Due Diligence- Intellectual Property Planning an IPR Due Diligence Exercise Patents - Planning a Strategy
Chapter 4: Gaining Access to Technology and Information- Confidentiality Issues
Chapter 5: Issues of Negotiation
Chapter 6: Overview of Letters of Intent Research Agreements
Chapter 7: Financial Evaluation of Opportunities
Chapter 8: Developing and Drafting the Agreement Performance by the Licensee
Chapter 9: Focus on: Confidentiality and Intellectual Property Rights Patents
Chapter 10: Focus on: European Competition and Free Movement Law Parallel Imports
Chapter 11: Focus on: Regulatory Affairs